Busca avançada
Ano de início
Entree

Morena Brazil Martins Sant'Anna

CV Lattes ResearcherID ORCID


Secretaria da Saúde (São Paulo - Estado). Instituto Butantan  (Instituição-sede da última proposta de pesquisa)
País de origem: Brasil

Possui graduação em Fisioterapia pela Universidade de São Paulo - FMRP (2012) e mestrado em Ciências (Faculdade de Medicina de Ribeirão Preto - Departamento de Farmacologia) pela Universidade de São Paulo (2014). Especialização Lato Sensu em Acupuntura Sistêmica, pelo Instituto Paulista de Estudos Sistêmicos. Doutorado em Ciências (Programa de pós-graduação em Toxinologia), pelo Instituto Butantan (2018) e Treinamento em Metabolismo e Farmacocinética (Drug Metabolism and Pharmacokinetic - DMPK) pelo Wellcome Centre for Anti-Infectives Research (W-CAIR) da Universidade de Dundee, Escócia. Atualmente, ingressou na pós-doutorado (PNPD) e desenvolve seus trabalhos no Laboratório de Dor e Sinalização do Instituto Butantan. (Fonte: Currículo Lattes)

Matéria(s) publicada(s) na Agência FAPESP sobre o(a) pesquisador(a)
Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica 
Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica 
Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico 
Matéria(s) publicada(s) em Outras Mídias (83 total):
Mais itensMenos itens
UOL: Nova formulação permite usar toxina do veneno da cascavel para tratar dor (25/Abr/2020)
Pfarma: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (20/Nov/2020)
Espaço Ecológico no Ar: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Abr/2020)
LabNetwork: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Abr/2020)
Revista Pará: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Abr/2020)
Fatos do Iguaçu online: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Abr/2020)
Diário da Região (São José do Rio Preto, SP) online: Nova formulação permite usar toxina do veneno de cascavel para tratar dor crônica (22/Abr/2020)
Agrosoft: NOVA FORMULAÇÃO PERMITE USAR TOXINA DO VENENO DA CASCAVEL PARA TRATAR DOR CRÔNICA (22/Abr/2020)
JC Notícias (São Paulo, SP): Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Abr/2020)
Atemporal: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Abr/2020)
Portal da Enfermagem: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Abr/2020)
Blog A Crítica: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Abr/2020)
Innovaspain (Espanha): Veneno de serpiente de cascabel para combatir el dolor crónico (11/Mar/2020)
News Break (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (11/Mar/2020)
Pregon Agropecuario (Argentina): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (10/Mar/2020)
NCYT Amazings (Espanha): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (09/Mar/2020)
Catalunya Vanguardista (Espanha): Veneno de serpiente cascabel para tratar el dolor crónico (09/Mar/2020)
Herencia Genetica y Enfermedad (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (24/Fev/2020)
AuroBlog: We Just Got Closer to Producing Painkillers From Rattlesnake Venom (24/Fev/2020)
International Business Times (Singapura): Snakes or life savers? New painkillers from Rattlesnake venom may provide relief to millions (23/Fev/2020)
ScienceAlert (Austrália): We Just Got Closer to Producing Painkillers From Rattlesnake Venom (22/Fev/2020)
Daniel Aleart (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (19/Fev/2020)
Buffalo X Press: Brazilian Researchers Prove Crotoxin’s Therapeutic Effects Can Cure Chronic Pain (19/Fev/2020)
Science Bulletin: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (18/Fev/2020)
SerTox (Argentina): Better analgesic effect of crotoxin by encapsulating it in nanostructured silica, study (18/Fev/2020)
SerTox (Argentina): Logran mejor efecto analgésico de la crotoxina al encapsularla en sílice nanoestructurada (18/Fev/2020)
Vechnayamolodost (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Fev/2020)
Polit News (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Fev/2020)
Newstes (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Fev/2020)
Polit (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Fev/2020)
UGPressa (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Fev/2020)
Phys.Org (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (17/Fev/2020)
European Pharmaceutical Review: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Fev/2020)
IntraMed (Argentina): Estudio en animales con veneno de serpiente de cascabel | Nueva formulación de Crotoxina para tratar el dolor crónico (17/Fev/2020)
Bioquick News (EUA): Novel Formulation Permits Use of Toxin from Rattlesnake Venom to Treat Chronic Pain (17/Fev/2020)
PressBoltNews (Índia): Health and medical Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Fev/2020)
FarsNews Agency (Irã): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Fev/2020)
Archyworldys: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Fev/2020)
Technologie Média: Un nouvel analgésique venant du serpent à sonnette (17/Fev/2020)
Small Tech News: Rattlesnake venom complex or can become a new effective painkiller (17/Fev/2020)
News Medical (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Fev/2020)
RCTopNews: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Fev/2020)
Medindia (Índia): Toxin from Rattlesnake Venom to Treat Chronic Pain (15/Fev/2020)
FBI Reform (EUA): Eurasia Review: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Fev/2020)
Lab Manager (Canadá): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
WNDU 16 (EUA): Toxin From Rattlesnake Venom Formulated to Treat Chronic Pain (15/Fev/2020)
Bizsiziz: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Obor News: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Fev/2020)
Bio1000 (China): 新的配方允许使用响尾蛇毒液中的毒素治疗慢性疼痛 (15/Fev/2020)
Alien Gossip (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Trap Town (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Vijayawada Now (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
The WB Mirror: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Zaker (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Kejik.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
QQ.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
System Daquan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Caiyisou (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Xiang Fang News (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
KE jūn I zhāiyào: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Xoer (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Niuzhan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
SOHU.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
HEA - Health Essence of Asia Group (Taiwan): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Blog WONGCW (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Tech Sina (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
cnBeta (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Fev/2020)
Bioengineer (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Health Medicine Network (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Science Codex: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
New Atlas (Austrália): Rattlesnake venom compound points to promising new painkiller (14/Fev/2020)
Nanotechnology Now (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Long Room (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Eurasia Review (Espanha): Using Toxin From Rattlesnake Venom To Treat Chronic Pain (14/Fev/2020)
SciTech Daily (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Scienmag Science Magazine (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Pharma Jobs: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
7thSpace: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Scienstack: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Tech Deeps: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Daily Tend (Paquistão): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
HNewspaper: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
RCTopNews: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Fev/2020)
Bolsas no país
Apoio FAPESP em números * Quantidades atualizadas em 28/11/2020
2 Bolsas no país concluídas

Processos vinculados
Colaboradores mais frequentes em auxílios e bolsas FAPESP
Contate o Pesquisador

Este canal da BV/FAPESP deve ser utilizado tão somente para mensagens, referentes aos projetos científicos financiados pela FAPESP.


 

 

 

 

Palavras-chave utilizadas pelo pesquisador
Publicações resultantes de Auxílios e Bolsas sob responsabilidade do(a) pesquisador(a) (1)

(Referências obtidas automaticamente do Web of Science e do SciELO, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores)

SANT'ANNA, MORENA BRAZIL; RIBEIRO LOPES, FLAVIA SOUZA; KIMURA, LOUISE FAGGIONATO; GIARDINI, ALINE CAROLINA; SANT'ANNA, OSVALDO AUGUSTO; PICOLO, GISELE. Crotoxin Conjugated to SBA-15 Nanostructured Mesoporous Silica Induces Long-Last Analgesic Effect in the Neuropathic Pain Model in Mice. TOXINS, v. 11, n. 12, . Citações Web of Science: 1. (15/01254-1, 08/57898-0, 17/17844-8, 14/19397-0)

Por favor, reporte erros na informação da página do pesquisador escrevendo para: cdi@fapesp.br.
X

Reporte um problema na página


Detalhes do problema: